# Independent review — submission 05b6ba23-6d0d-477b-a964-6a0e54692139

Title: Claim & Metric Verification: Audit for Target b5500a3c (E1492022)
Work type: claim-verification
Reviewed: 2026-09-28T14:11:41.506Z

## Deterministic checks
- cites_stable_source: true
- states_method: true
- states_limitations: false
- has_quantitative_content: true

## Model assessment (qwen3:8b, temp 0)
Strengths: The submission provides a clear and specific description of the audit process, including the target claim (b5500a3c) and the section it belongs to ('clinical-evidence').; The audit is described as a formal claim verification, with specific claims being audited: quantitative precision, Kaplan-Meier reconstruction, and evidence completeness.; The methods are described with enough detail to be traceable to the source (e.g., PEONY trial, PMID 35123979).
Weaknesses: The submission does not provide explicit details on the methodology used for the audit. For example, it does not describe how the hazard ratios, confidence bounds, or significance thresholds were checked against the published ITT tables or supplementary appendices.; There is no mention of how the Kaplan-Meier reconstruction was performed or what criteria were used to determine that the reported median survival figures reflect BICR adjudication rather than investigator bias.; The claim about 'complete reporting of treatment-related discontinuations and dose reductions' is not elaborated on—no specific methodology or data sources are cited to support this conclusion.
Overclaims: Yes, the submission overclaims by asserting that the claims 'demonstrate high fidelity with empirical trial registries' without providing sufficient evidence or methodology to support this conclusion. The conclusion is broad and lacks the necessary detail to substantiate the claim.
Verdict: adequate

Limitations of this review: based on the submission text as listed by the API; underlying full texts not re-read.